ZERT Trademark

Trademark Overview


On Wednesday, July 19, 2023, a trademark application was filed for ZERT with the United States Patent and Trademark Office. The USPTO has given the ZERT trademark a serial number of 98091216. The federal status of this trademark filing is SUSPENSION LETTER - MAILED as of Monday, April 29, 2024. This trademark is owned by Globet Inc. The ZERT trademark is filed in the Insurance & Financial Services category with the following description:

Currency trading; Financial exchange of crypto assets; Financial services, namely, electronic transfer of crypto assets
zert

General Information


Serial Number98091216
Word MarkZERT
Filing DateWednesday, July 19, 2023
Status653 - SUSPENSION LETTER - MAILED
Status DateMonday, April 29, 2024
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateNOT AVAILABLE

Trademark Statements


Goods and ServicesCurrency trading; Financial exchange of crypto assets; Financial services, namely, electronic transfer of crypto assets
Translation of Words in MarkThe wording "ZERT" has no meaning in a foreign language.

Classification Information


International Class036 - Insurance; financial affairs; monetary affairs; real estate affairs.
US Class Codes100, 101, 102
Class Status Code6 - Active
Class Status DateThursday, August 17, 2023
Primary Code036
First Use Anywhere DateThursday, January 1, 1970
First Use In Commerce DateThursday, January 1, 1970

Trademark Owner History


Party NameGlobet Inc
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressMiami, US 33131

Trademark Events


Event DateEvent Description
Saturday, July 22, 2023NEW APPLICATION ENTERED
Thursday, August 17, 2023NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Monday, March 25, 2024ASSIGNED TO EXAMINER
Friday, April 19, 2024AMENDMENT CORRESPONDENCE ENTERED
Monday, April 29, 2024LETTER OF SUSPENSION E-MAILED
Monday, April 29, 2024NOTICE OF SUSPENSION SENT - PENDING REVIEW